NCT07509918

Brief Summary

This randomized clinical trial compares tannic acid-zinc acetate mucoadhesive gel with lidocaine gel for reducing gag reflex in children aged 8-10 years during radiographic dental examination Gag reflex severity and pulse rate will be assessed before and after gel application. The study evaluates the effectiveness of the tested gel as a potential alternative to lidocaine.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P50-P75 for not_applicable

Timeline
2mo left

Started Sep 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 28, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 3, 2026

Completed
5 months until next milestone

Study Start

First participant enrolled

September 1, 2026

Expected
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2026

1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2026

Last Updated

April 8, 2026

Status Verified

March 1, 2026

Enrollment Period

1 month

First QC Date

March 28, 2026

Last Update Submit

April 2, 2026

Conditions

Keywords

Gag reflexRadiographic dental examinationPediatric dentistryMucoadhesive gels

Outcome Measures

Primary Outcomes (1)

  • Gag reflex severity score using a 5-point Likert faces scale

    Gag reflex severity is assessed using a 5-point Likert faces scale (score range: 0-5), where higher scores indicate greater gag reflex severity, following application of the assigned topical gel during the dental procedure.

    Immediately after gel application during the dental procedure (single visit)

Secondary Outcomes (1)

  • Pulse rate (beats per minute)

    During the dental procedure (single visit)

Study Arms (3)

Participants receive topical tannic acid mucoadhesive gel.

EXPERIMENTAL

tannic acid mucoadhesive gel applied intraorally prior to the dental procedure to evaluate its effectiveness in reducing gag reflex

Drug: Tannic Acid Mucoadhesive Gel (Topical)

Participants receive topical zinc acetate mucoadhesive gel

EXPERIMENTAL

zinc acetate mucoadhesive gel applied intraorally prior to the dental procedure to assess its effect on gag reflex reduction.

Drug: Zinc Acetate Mucoadhesive Gel (Topical)

Participants receive topical lidocaine gel

ACTIVE COMPARATOR

lidocaine gel applied intraorally prior to the dental procedure as a standard treatment comparator for gag reflex control

Drug: Lidocaine Gel (Topical)

Interventions

A mucoadhesive gel containing tannic acid at a specified concentration is applied topically to the oral mucosa prior to the dental procedure. The gel is intended to reduce gag reflex through its astringent and protein-precipitating properties.

Participants receive topical tannic acid mucoadhesive gel.

A mucoadhesive gel containing zinc acetate at a specified concentration is applied topically to the oral mucosa before the dental procedure. The formulation is used to evaluate its potential effect in reducing gag reflex.

Participants receive topical zinc acetate mucoadhesive gel

A topical lidocaine gel at an appropriate concentration is applied to the oral mucosa prior to the dental procedure as a standard local anesthetic agent for gag reflex suppression.

Participants receive topical lidocaine gel

Eligibility Criteria

Age8 Years - 10 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • The study will include children aged between 8 and 10 years .
  • Pediatric dental patients requiring intraoral radiographs for diagnostic or treatment purposes will be recruited.
  • Children present with a fully erupted maxillary last molar to allow standardized placement of the radiographic film for gag reflex stimulation.
  • Written informed consent will be obtained from parents or legal guardians before participation.

You may not qualify if:

  • Children with systemic diseases or neurological disorders that may influence gag reflex,such as epilepsy or cerebral palsy.
  • Those with a history of allergies to the materials that will be used in the study gels are not considered eligible.
  • Patients with acute respiratory infections, oropharyngeal inflammation, or enlarged tonsils at the time of the examination are excluded to avoid confounding variables.
  • Children taking medications known to modify gag reflex or pulse rate, such as sedatives or antihistamines, are not included.
  • Uncooperative or extremely anxious children, classified as Frankl ratings 1 or 2, are excluded

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of dentistry Cairo university

Cairo, Egypt

Location

Related Publications (4)

  • Elbay M, Tak O, Sermet Elbay Ü, et al. The use of low-level laser therapy for controlling the gag reflex in children during intraoral radiography. Lasers in Medical Science. 2016;31(2):355-361.

    BACKGROUND
  • Nikkerdar N, Seyedi H, Mirzaeei S, et al. Comparative effects of three mucoadhesive gels containing lidocaine, zinc acetate, and tannic acid on the gag reflex of dental patients: a randomized double-blind clinical trial. BMC Oral Health. 2024;24:1442

    BACKGROUND
  • Eachempati P, Kumbargere Nagraj S, Karanth L. Management of gag reflex for patients undergoing dental treatment. Cochrane Database of Systematic Reviews. 2019;(11):CD011116.

    BACKGROUND
  • Bassi GS, Humphris GM, Longman LP. The etiology and management of gagging: a review of the literature. Journal of Prosthetic Dentistry. 2004;91(5):459-467.

    BACKGROUND

MeSH Terms

Conditions

Gagging

Condition Hierarchy (Ancestors)

Signs and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Mahmoud Hamdy Eid, Professor

    Faculty of Dentistry, Cairo University, Cairo, Egypt

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sara Usama Elkholy, Dental degree

CONTACT

Mohamed Atef Abdelhakim, Dental

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dentist

Study Record Dates

First Submitted

March 28, 2026

First Posted

April 3, 2026

Study Start (Estimated)

September 1, 2026

Primary Completion (Estimated)

October 1, 2026

Study Completion (Estimated)

November 1, 2026

Last Updated

April 8, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared to protect participant confidentiality and due to institutional policies.

Locations